deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02860039

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients

Sponsor: National Cancer Institute (NCI)

Conditions Hematopoietic Cell Transplantation Recipient Influenza Malignant Neoplasm
Interventions Laboratory Biomarker Analysis Quadrivalent Influenza Vaccine Trivalent Influenza Vaccine
Updated 20 times since 2017 Last updated: Oct 10, 2024 Started: Sep 30, 2016 Primary completion: Dec 1, 2021 Completion: Sep 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Hematopoietic Cell Transplantation Recipient and Influenza, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 20 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Nov 2018 · 3 months · monthly snapshot~Nov 2018 – ~Aug 2019 · 9 months · monthly snapshot~Aug 2019 – ~Nov 2019 · 3 months · monthly snapshot~Nov 2019 – ~Mar 2020 · 4 months · monthly snapshot~Mar 2020 – ~May 2020 · 2 months · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Sep 2021 · 6 months · monthly snapshot~Sep 2021 – ~May 2022 · 8 months · monthly snapshot~May 2022 – ~Sep 2022 · 4 months · monthly snapshot~Sep 2022 – ~Jan 2023 · 4 months · monthly snapshot~Jan 2023 – ~Jun 2023 · 5 months · monthly snapshot~Jun 2023 – ~Mar 2024 · 9 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – present · 22 months · monthly snapshot

Change History

20 versions recorded

  1. Nov 2024 — Present [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  2. Sep 2024 — Nov 2024 [monthly]

    Active Not Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  4. Mar 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

  5. Jun 2023 — Mar 2024 [monthly]

    Active Not Recruiting PHASE2

▶ Show 15 earlier versions

  1. Jan 2023 — Jun 2023 [monthly]

    Active Not Recruiting PHASE2

  2. Sep 2022 — Jan 2023 [monthly]

    Active Not Recruiting PHASE2

  3. May 2022 — Sep 2022 [monthly]

    Active Not Recruiting PHASE2

  4. Sep 2021 — May 2022 [monthly]

    Active Not Recruiting PHASE2

  5. Mar 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE2

  6. Jan 2021 — Mar 2021 [monthly]

    Active Not Recruiting PHASE2

  7. May 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  8. Mar 2020 — May 2020 [monthly]

    Recruiting PHASE2

  9. Nov 2019 — Mar 2020 [monthly]

    Recruiting PHASE2

    Status: Suspended → Recruiting

  10. Aug 2019 — Nov 2019 [monthly]

    Suspended PHASE2

    Status: Recruiting → Suspended

  11. Nov 2018 — Aug 2019 [monthly]

    Recruiting PHASE2

    Status: Suspended → Recruiting

  12. Aug 2018 — Nov 2018 [monthly]

    Suspended PHASE2

    Status: Recruiting → Suspended

  13. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE2

  14. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  15. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Sep 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • Vanderbilt-Ingram Cancer Center
Data source: Vanderbilt-Ingram Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations